… Also, we searched in ClinicalTrials for ‘COVID-19’ ongoing studies … cytokine storm. From
this, we also researched the same databases for the rationale of using those drugs in COVID-19…

… This study suggests increase of pro-inflammatory cytokines in COVID-19 patients and may
be helpful in development of predictive models to predict severe disease at early stages SARS…

… In addition to the deregulated cytokine response, COVID-19 … , and defective lymphocyte
responses were reported in … immune responses and unsolved inflammation in COVID-19 patients…

… status in patients with COVID-19, could be helpful for … , at least at present, in COVID-19.
Currently available experimental and … COVID-19, with a specific focus on their role in the cytokine …

… during the early stages of the COVID-19 pandemic, ranging from targeting the virus … cytokine
response. Among the different agents to manage cytokine storm in patients with COVID-19, …

… Therefore, in this study, those genetic variations mostly of encoding genes associated with
the immune responses to the COVID-19 disease predisposition or individual vulnerability …

… of pro-inflammatory cytokines was early identified in severe COVID-19 patients [66]. The
detection of viral RNA potentially drives activation of this transcriptional response by endosomal …

… -CSS has led to the off-label use of targeted anti-cytokine therapies aimed at blocking …
cytokine blockade in COVID-19. Currently there are no standard therapies for COVID-19 or COVID-…

… In contrast, serum levels of IL-6, IL-8 and IFNγ were elevated at baseline in COVID-19
subjects compared to healthy subjects with IL-6 (p = 0.006) and IL-8 (p = 0.011) levels being …

… exhibiting the T H 22 signature are plotted separately for visual comparison, they were
considered to represent regulated cytokine responses and were therefore included as COVID-…